Enfusion Stock Price on March 1, 2024
| ENFN Stock | USD 10.02 0.11 1.09% |
If you're considering investing in Enfusion Stock, it is important to understand the factors that can impact its price. As of today, the current price of Enfusion stands at 10.02, as last reported on the 28th of November, with the highest price reaching 10.18 and the lowest price hitting 9.83 during the day. Enfusion appears to be not too volatile, given 3 months investment horizon. Enfusion secures Sharpe Ratio (or Efficiency) of 0.16, which denotes the company had a 0.16% return per unit of risk over the last 3 months. We have found thirty technical indicators for Enfusion, which you can use to evaluate the volatility of the firm. Please utilize Enfusion's Coefficient Of Variation of 611.39, downside deviation of 1.75, and Mean Deviation of 1.62 to check if our risk estimates are consistent with your expectations.
At this time, Enfusion's Total Stockholder Equity is very stable compared to the past year. As of the 28th of November 2024, Other Stockholder Equity is likely to grow to about 238.2 M, while Common Stock Shares Outstanding is likely to drop about 111.4 M. . At this time, Enfusion's Price Fair Value is very stable compared to the past year. Enfusion Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Enfusion |
Sharpe Ratio = 0.1574
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ENFN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.04 actual daily | 18 82% of assets are more volatile |
Expected Return
| 0.32 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Enfusion is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enfusion by adding it to a well-diversified portfolio.
Price Book 13.672 | Enterprise Value Ebitda 49.5978 | Price Sales 4.8985 | Shares Float 37.9 M | Wall Street Target Price 9.6113 |
Enfusion Main Headline on 1st of March 2024
Acquisition by Bronwen Bastone of 104603 shares of Enfusion ... by Bronwen Bastone
Filed transaction by Enfusion Officer: Chief People Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Enfusion Valuation on March 1, 2024
It is possible to determine the worth of Enfusion on a given historical date. On March 1, 2024 Enfusion was worth 8.63 at the beginning of the trading date compared to the closed value of 8.67. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Enfusion stock. Still, in general, we apply an absolute valuation method to find Enfusion's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Enfusion where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Enfusion's related companies.
| Open | High | Low | Close | Volume | |
| 8.81 | 8.90 | 8.65 | 8.67 | 676,300 | |
03/01/2024 | 8.63 | 8.69 | 8.38 | 8.67 | 427,500 |
| 8.70 | 8.79 | 8.55 | 8.60 | 482,998 |
| Backtest Enfusion | | | Enfusion History | | | Enfusion Valuation | Previous | Next |
Enfusion Trading Date Momentum on March 1, 2024
| On March 04 2024 Enfusion was traded for 8.60 at the closing time. The top price for the day was 8.79 and the lowest listed price was 8.55 . The trading volume for the day was 483 K. The trading history from March 4, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.81% . The overall trading delta against the current closing price is 4.38% . |
Enfusion Fundamentals Correlations and Trends
By evaluating Enfusion's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Enfusion's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Enfusion financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Enfusion Stock history
Enfusion investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Enfusion is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Enfusion will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Enfusion stock prices may prove useful in developing a viable investing in Enfusion
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 129.4 M | 111.4 M | |
| Net Loss | -6.9 M | -7.2 M |
Enfusion Quarterly Net Working Capital |
|
Enfusion Stock Technical Analysis
Enfusion technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Enfusion Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Enfusion cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Enfusion November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Enfusion stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enfusion shares will generate the highest return on investment. By undertsting and applying Enfusion stock market strength indicators, traders can identify Enfusion entry and exit signals to maximize returns
Enfusion Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Enfusion's price direction in advance. Along with the technical and fundamental analysis of Enfusion Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Enfusion to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1313 | |||
| Jensen Alpha | 0.1813 | |||
| Total Risk Alpha | 0.0024 | |||
| Sortino Ratio | 0.1164 | |||
| Treynor Ratio | 0.2737 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.27) | Earnings Share 0.04 | Revenue Per Share 2.155 | Quarterly Revenue Growth 0.154 | Return On Assets 0.0592 |
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.